Patent ID: 11905244
Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 16:
17. A method of treatment of a disease, disorder, or condition treatable by inhibiting calcium release-activated calcium (CRAC) channel, comprising administering to a subject in need thereof an amount of a CRAC channel inhibitor effective to inhibit CRAC channel, wherein the CRAC channel inhibitor is a compound of Formula I:, or a pharmaceutically acceptable salt, solvate, or a hydrate thereof, wherein
X is an optionally substituted C6-C10 aryl or an optionally substituted C5-C10 heteroaryl;
Y is an optionally substituted phenethyl; and
Z is an optionally substituted C6-C10 aryl or an optionally substituted C5-C10 heteroaryl.